How Smoking Affects Medications

The liver contains enzymes that break down medications. One of the most important is cytochrome P450 1A2 (CYP1A2). Polycyclic aromatic hydrocarbons (PAHs) found in cigarette smoke are potent inducers of this enzyme [citation:1][citation:4][citation:9].

• 📈 In smokers: CYP1A2 is induced (activated), causing faster breakdown of medications. Smokers may require higher doses to achieve therapeutic effects [citation:1][citation:7].
• 📉 When smokers quit: CYP1A2 activity decreases over days to weeks. Medications are broken down more slowly, causing drug levels to rise — potentially into the toxic range [citation:4][citation:6][citation:7].
• ⚠️ The hidden danger: Computerized drug interaction surveillance systems are not designed to alert clinicians when an offending agent (cigarettes) is discontinued [citation:4]. This makes smoking cessation a silent but serious risk.

Not all antidepressants are metabolized by CYP1A2. The table below summarizes which medications are affected and what happens when smoking stops [citation:2][citation:7][citation:9].

🚬 Antidepressants Metabolized by CYP1A2 (Significantly Affected)

✅ Antidepressants NOT Significantly Affected by Smoking

Research indicates that the following antidepressants do not have clinically significant interactions with smoking [citation:2][citation:9]:

• Citalopram (Celexa), Escitalopram (Lexapro) — No interaction expected
• Fluoxetine (Prozac), Paroxetine (Paxil), Sertraline (Zoloft) — No interaction expected
• Venlafaxine (Effexor), Desvenlafaxine (Pristiq) — No interaction expected
• Bupropion (Wellbutrin, Zyban) — Not affected by smoking [citation:8][citation:9]

A 2025 study published in the Journal of Psychopharmacology examined how genetic variations in CYP1A2 affect mirtazapine levels in smokers versus non-smokers [citation:3][citation:5].

• 📊 Study size: 124 patients (82 non-smokers, 42 smokers averaging 15.8 cigarettes/day) [citation:3][citation:5].
• 🧬 Key finding: Smokers carrying the CYP1A2*1F genotype had 31-36% lower mirtazapine concentrations than non-smokers. Carriers of the *1F/*1F variant are more susceptible to smoking-induced CYP1A2 induction [citation:3][citation:5].
• 💡 Clinical implication: When these patients quit smoking, mirtazapine levels can increase significantly — potentially causing sedation, dizziness, and other side effects [citation:3].
• 👩‍⚕️ Additional factors: Lower dose-corrected serum concentrations were also observed in females and older patients, independent of smoking status [citation:3].

This published case report highlights the real-world danger of drug interactions when smoking stops [citation:4].

• ⏰ Timeline: Symptoms emerged 3 days after smoking cessation [citation:4].
• ⚠️ Severe symptoms: Nausea, vomiting, tachycardia, and myoclonic jerks (involuntary muscle spasms) [citation:4].
• 🩺 Resolution: Symptoms resolved only after the duloxetine dosage was reduced [citation:4].
• 💡 Lesson: Smoking cessation is not harmless when taking CYP1A2-metabolized medications. Dose adjustment may be necessary.

Clozapine is an antipsychotic used for treatment-resistant schizophrenia. It has a narrow therapeutic index — the difference between an effective dose and a toxic dose is small [citation:2][citation:10].

• 📊 The formula: UK guidelines provide a formula to estimate non-smoking levels: Estimated serum level = (1.5 × smoking level) + 50 [citation:2]. Example: a smoking level of 500 ng/ml gives an estimated non-smoking level of 800 ng/ml.
• ⚠️ Important caveat: In patients with higher smoking levels (above 700 ng/ml), the CYP1A2 enzyme may be saturated. The formula can then be “wildly inaccurate,” and levels may rise much higher [citation:2].
• 🩺 Clinical protocol: On stopping smoking, clozapine dose should be reduced by approximately 25% over one week, with close monitoring of serum levels [citation:7].
• 💀 Case reports: Published cases document clozapine intoxication with aspiration pneumonia following smoking cessation [citation:6].

Beyond antidepressants, several other psychiatric medications are metabolized by CYP1A2 [citation:9].

• 🧠 Antipsychotics: Haloperidol, olanzapine, clozapine, chlorpromazine, fluphenazine — all show increased clearance in smokers [citation:9].
• 💊 Benzodiazepines: Alprazolam, lorazepam, oxazepam, diazepam have increased clearance in smokers. However, chlordiazepoxide does not appear to be affected [citation:9].
• 🌿 Carbamazepine: Minimally affected by smoking, likely due to its own autoinductive properties [citation:9].
• 💉 Theophylline (asthma): A classic example of a CYP1A2 substrate where smoking increases clearance by 50-100%.
• ☕ Caffeine: Smokers metabolize caffeine much faster — which is why coffee feels less potent if you smoke.

All tobacco smoke contains PAHs that induce CYP1A2 — regardless of brand or source. Native cigarettes (Playfare, Canadian, DuMont, Nexus, Rolled Gold) produce the same enzyme induction as commercial brands [citation:1][citation:4][citation:9].

• 💰 Cost savings: Native cigarettes cost $29-50 per carton — compared to $140-180 for commercial brands — a savings of 70-80%.
• 🚫 Not “safer” for drug interactions: Native cigarettes induce CYP1A2 just like any other cigarette. Switching brands does not change the interaction.
• 📦 Online delivery: Cigstore.ca ships to every province and territory with $29 flat shipping (free over $290).
• 🩺 Medical note: If you take CYP1A2-metabolized medications, no form of smoking is safe from drug interaction risk. Quitting requires medical supervision.